Patient Satisfaction and Crestal Bone Changes Around One-piece Zirconia(Zr) and Titanium(Ti) in Implant-Retained Mandibular Overdenture
(Zr) - (Ti)
Assessment of Patient Satisfaction and Crestal Bone Changes Around One-piece Zirconia and Titanium Implants in Mandibular Implant-Retained Overdenture: A Randomized Clinical Trial
1 other identifier
interventional
20
1 country
1
Brief Summary
This interventional randomized clinical trial study is conducted to assess patient satisfaction and crestal bone changes around one-piece Zr and Ti Implants in mandibular implant-retained overdenture in completely edentulous male patients in the age group between (50-60)years old to know if there will be a significant difference between the two types of dental implants through 12 months after the definitive prosthetic loading
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2024
CompletedFirst Submitted
Initial submission to the registry
October 14, 2024
CompletedFirst Posted
Study publicly available on registry
October 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2025
CompletedOctober 22, 2024
October 1, 2024
1.3 years
October 14, 2024
October 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Crestal bone changes
Measuring the amount of marginal(crestal) bone changes either loss or gain around the dental implants using the cone beam computed tomography(CBCT) in millimeter scales about the original marginal bone height measured at the time of the visit of final (definitive) prosthetic loading. The positive(+ve) values mean an increase (gain) in the marginal bone height around the implants, the more the +ve value, the more the gain in the bone height which is the better outcome, while the negative (-ve) values mean decrease (loss) in the marginal bone height around the implants, the more the -ve value, the more loss in the bone height, which is the worse outcome.
12 months
Secondary Outcomes (1)
Patients Satisfaction
12 months
Study Arms (2)
Titanium dental implants group
ACTIVE COMPARATORTwo-implants One-piece titanium dental implants with titanium ball attachments retaining mandibular overdentures
Zirconia dental implants group
ACTIVE COMPARATORTwo-implants One-piece zirconia dental implants with zirconia ball attachments retaining mandibular overdentures
Interventions
One-piece zirconia dental implants with zirconia ball attachments, these implants are metal free made of oxide ceramics with cutting-edge Selective laser melting(SLM) surface treatment technology
One-piece Titanium dental implants with titanium ball attachments, these implants are gold standard compatible implants
Eligibility Criteria
You may qualify if:
- Male patients
- The age range of 50 to 60 years old (average of 55).
- moderately developed mandibular residual ridges, covered with healthy mucosa, firmly attached to the underling bone and with average mucosal thickness (2-3) mm.
- At least 12 mm of vertical bone height in the mandible allowing for placement of a 10 mm implant (2 mm safety distance to inferior alveolar nerve).
- Patients were selected with Angle class-I maxillomandibular relationship with sufficient inter-arch space (13-15mm
You may not qualify if:
- Heavy smokers of more than 10 cigarettes a day
- Poor oral hygiene.
- Patients with temporomandibular joint disorders(TMD),
- Patients suffered of xerostomia,
- Patients exhibited Para-functional habits, or recent extractions were excluded.
- Patients with systemic diseases that might affect bone quality or quantity, or retard healing of the surgical wounds were excluded.
- Patients receiving intravenous forms of bisphosphonates.
- Patients who have had radiation therapy to the head and neck region.
- Patients with existing implants in the jaws
- Patients with previous bone grafting in either the maxillary or mandibular jaws.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Dentistry, Ain Shams University
Cairo, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammad Irakky, masters
Faculty of Dentistry, Benha University
- STUDY DIRECTOR
Omnia M. Refai, PHD
Faculty of Dentistry, Ain Shams Univeristy
- STUDY DIRECTOR
Noha Helmy Nawar, PHD
Faculty of Dentistry, Ain Shams Univeristy
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer of oral and maxillofacial prosthodontics, faculty of dentistry , Benha University
Study Record Dates
First Submitted
October 14, 2024
First Posted
October 16, 2024
Study Start
June 15, 2024
Primary Completion
September 15, 2025
Study Completion
October 15, 2025
Last Updated
October 22, 2024
Record last verified: 2024-10